RGEN – repligen corporation (US:NASDAQ)

News

Repligen (NASDAQ:RGEN) was downgraded by analysts at Weiss Ratings from a "hold (c-)" rating to a "sell (d+)" rating.
2 Cash-Producing Stocks to Target This Week and 1 We Ignore [Yahoo! Finance]
UBS Tags Repligen (RGEN) as Bioprocessing Leader for 2026, Cites 20% Order Growth and Reshoring Tailwinds [Yahoo! Finance]
???????????????????????2026:??????????????? [CNET News]
Conestoga SMid Cap Composite Q4 2025 Commentary [Seeking Alpha]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com